Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone-Reference-Cited by-同舟云学术

Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone

Published:2024-07 Issue: Volume:128 Page:107527
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Bartko Theresa M.,Lutgen Stephen M.,Ross Rebecca A.,Walisser Jacqueline A.,Garske Eric P.,Kopelke Kerry R.,Ashcroft-Hawley Kelly,Tang Hai-Ming,Kremer John J.,Friedrichs Gregory S.,Nichols Jill V.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Reference29 articles.

1. ICH E14/S7B implementation working group: E14/S7B questions and answers: Clinical and nonclinical evaluation of QT/QTc interval prolongation and Proarrhythmic potential;Anonymous;Training Materials,2022

2. Heart rate corrected JTp and TpTe as proarrhythmia biomarkers in safety pharmacology non-human primate studies: Outcome from a HESI consortium prospective study;Authier,2023

3. JTpeak assessment in ambulatory dog and monkey an update from the HESI working group;Authier,2022

4. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens;Brien;Drug Metabolism and Disposition,1990

5. Species differences in drug plasma protein binding;Colclough;Medicinal Chemistry Communications,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative approaches to cardiovascular safety pharmacology assessment;Journal of Pharmacological and Toxicological Methods;2024-07